Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine

Immunopharmacology

Volumn 48, Issue 1, 2000, Pages 9-16

  Marinova, Ekaterina K ^a   Nikolova, Diana B ^a   Popova, Dora N ^b   Gallacher, Gergana B ^c   Ivanovska, Nina D ^d  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

Autoimmune tubulointerstitial nephritis; BALB c mice; Berberine; Suppression

Indexed keywords

BERBERINE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; INTERSTITIAL NEPHRITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS; AUTOIMMUNE DISEASES; BASEMENT MEMBRANE; BERBERINE ALKALOIDS; CD4 LYMPHOCYTE COUNT; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; NEPHRITIS, INTERSTITIAL;

EID: 0034102171     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00189-7     Document Type: Article

References (23)

1. Bonnefoy-Berard N., Fournel S., Genestier L., Quemeneur L., Flacher M., Revillard J. In vitro functional properties of antithymocyte globulins: clues for new therapeutic applications. Abstract Book. 3rd International Conference on New Trends in Clinical and Experimental Immunosuppression-Geneva:1998;162.
2. Boonstra J., Van Der Woude F., Wever P., Laterveer J., Daha M., Van Kooten C. Expression and function of FAS/CD95/ on human renal tubular epithelial cells. J. Am. Soc. Nephrol. 8:1997;1517-1524.
3. Brentjens J., Noble B., Andres G. Immunologically mediated lesions of kidney tubules and interstitium in laboratory animals and man. Springer Semin. Immunopathol. 5:1983;357-378.
4. Cher D.J., Mosmann T.R. Two types of murine helper T cell clone: II. Delayed-type hypersensitivity is mediated by TH1 clones. J. Immunol. 138:1989;3688-3694.
5. Chi C.W., Chang Y.F., Chao T.W., Chiang S.H., P'eng F.K., Lui W.Y., Liu T.Y. Flowcytometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells. Life Sci. 54:1994;2099-2107.
6. Ckless K., Schlottfeldt J., Pasqual M., Moyna P., Henriques J., Wajner M. Inhibition of in vitro lymphocyte transformation by the isoquinoline alkaloid berberine. J. Pharm. Pharmacol. 47:1995;1029-1031.
7. Cluskey R., Colvin R. Immunologic studies of tubulointerstitial nephritis. Cluskey R. Immunology of Renal Disease. 1982;125-147 Pergamon.
8. Dhillon S., Higgins R. Interstitial nephritis. Postgrad. Med. J. 73:1997;151-155.
9. Goldman M., Druet P. The TH1/TH2 concept and relevance to renal disorders and transplantation immunity. Nephrol., Dial., Transplant. 10:1995;1282-1284.
10. Hogan M., Vogel S. Cytokines and their cellular receptors. Curr. Protoc. Immunol. 6:1991;10.1-10.5.
11. Ivanovska N., Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int. J. Immunopharmacol. 18:1996;553-561.
12. Landay A., Muirhead K. Procedural guidelines for performing immunophenotyping by flow cytometry. Clin. Immunol. Immunopathol. 52:1989;48-60.
13. Lycke N. Immunologic studies in humans. Curr. Protoc. Immunol. 7:1991;14.1-14.7.
14. Neilson E., Phillips M. Cell-mediated immunity in interstitial nephritis. T Lymphocyte systems in nephritic guinea pigs: the natural history and diversity of the immune response. J. Immunol. 123:1979;5-10.
15. Nikolova D., Nikolova E., Marinova E., Kitova G. Modulation of humoral and cell-mediated cytotoxic reactions in guinea pigs with experimental autoimmune tubulointerstitial nephritis by cytostatics. C. R. Acad. Sci. 49:1996;113-116.
16. Nikolova D., Nikolova E., Marinova E., Kitova G. Adverse dose-dependent effect of cimetidine on guinea pigs with experimental autoimmune tubulointerstitial nephritis. C. R. Acad. Sci. 50:1997;97-100.
17. Rastegar A., Kashgarian H. The clinical spectrum of tubulointerstitial nephritis. Kidney Int. 54:1998;313-327.
18. Revillard J., Genestier L., Fournel S., Paillot R., Ferraro S., Bonnefoy-Berard N. Activation dependent apoptosis and clonal deletion of peripheral T cells. Abstract Book. 3rd International Conference on New Trends in Clinical and Experimental Immunosuppression - Geneva:1998;54.
19. Rudofsky U., Dilwith R., Tung K. Susceptibility differences of inbred mice to induction of autoimmune renal tubulointerstitial lesions. Lab. Invest. 43:1980;463-469.
20. Rudofsky U., Pollara B. Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea pigs. Clin. Immunol. Immunopathol. 6:1976;107-114.
21. Ulich T., Banister K., Wilson C. Tubulointerstitial nephritis induced in the Brown Norway rat with chaotropically solubilized bovine tubular basement membrane. Clin. Immunol. Immunopathol. 36:1985;187-200.
22. Wilson C. Study of the immunopathogenesis of tubulointerstitial nephritis using model systems. Kidney Int. 35:1989;938-953.
23. Yang I.W., Chou C.C., Yung B.Y., Naunyn B. Dose-dependent effects of berberine on cell cycle pause and apoptosis in BALB/c 3T3 cells. Schmiedeberg's Arch. Pharmacol. 354:1996;102-108.